ITGAM and pleural neoplasm: At day 13 after pleural injection of MC38 cells (KrasG13R), deltarasin-treated C57BL/6 mice developed fewer and smaller MPEs, retarded pleural tumour dissemination and decreased pleural CD11b+Gr1+ accumulation compared with controls (Fig. 5a; Table 5).